What are temporary pacing leads?
Temporary leads are used in more than 350,000 procedures each year, a number that is growing rapidly as the population ages and transcatheter aortic valve replacement (TAVR) becomes increasingly common. The temporary pacing lead, a small catheter with two electrodes, is placed in the right ventricle of the heart through a vein in the groin or neck. The lead is then connected to an external pacemaker allowing a physician to monitor and control a patient’s heart rate for up to several days.
Current temporary pacing leads can cause complications
The design of conventional temporary pacing leads can cause serious complications. Current temporary leads can be easily dislodged from the heart, which may result in loss of pacing, with serious consequences for the patient. As a result, patients are often limited to bed rest for the duration of temporary pacing lead placement, delaying ambulation and thereby increasing length of stay in costly hospital units such as intensive care. In addition, current leads risk perforation of the heart wall, which may lead to pericardial effusion and tamponade, in which blood from within the heart escapes into the sac surrounding the heart, leading to potentially life-threatening cardiac compression.
Introducing the Tempo® Temporary Pacing LeadBioTrace Medical’s Tempo® Lead incorporates innovations designed for secure and stable cardiac pacing with the goal of reducing complications and allowing patients to ambulate sooner after procedures.
The Tempo® Lead features a novel active fixation mechanism, bipolar electrodes and a soft tip. An elastomeric balloon may be inflated to aid passage of the lead through the venous vasculature and into the right ventricle, and aids in orienting the lead.
News & Events
March 31, 2017
The MedTech Strategist: Serving a Growing TAVR Market With Safer Temporary Pacing [read more]
March 17, 2017
Qmed: Better Temporary Leads Could Offer Alternative to Permanent Pacemakers for TAVR Patients [read more]
Dec. 20, 2016
Medical Product Manufacturing News: Could BioTrace Set A New ‘Tempo’ for Temporary Pacing? [read more]
Dec. 19, 2016
BioTrace Medical Announces First U.S. Patients Treated with Company’s Innovative Temporary Pacing Lead [read more]
Oct. 31, 2016
BioTrace Medical Announces Positive Data From Clinical Study of Innovative Temporary Pacing Technology [read more]
Oct. 27, 2016
BioTrace Medical Announces FDA Clearance of Innovative Temporary Pacing Technology for Transcatheter Aortic Valve Procedures and Other Cardiovascular Applications [read more]
BioTrace Medical Inc.
831 Bransten Road, Suite L
San Carlos, CA 94070
Use Per FDA Cleared Labeling
The devices, systems and services described on this Website are subject to United States laws governing the use and sale of such devices, systems and services. Nothing in this Website is intended to constitute a claim or indication for clinical uses of BioTrace’s medical devices beyond those that have been cleared or approved by the U.S. Food and Drug Administration or any foregoing equivalent, as applicable.